504191 Sigma-AldrichCB1 agonist ACEA - CAS 220556-69-4 - Calbiochem
Synonymes: N-(2-Chloroethyl)-5Z,8Z,11Z,14Z-eicosatetraenamide
Produits recommandés
Aperçu
Replacement Information |
---|
Tableau de caractéristiques principal
CAS # | Empirical Formula |
---|---|
220556-69-4 | C₂₂H₃₆ClNO |
Product Information | |
---|---|
CAS number | 220556-69-4 |
Form | Clear to pale yellow liquid |
Formulation | Supplied in MeOAc |
Hill Formula | C₂₂H₃₆ClNO |
Chemical formula | C₂₂H₃₆ClNO |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | CB₁ Receptor |
Primary Target K<sub>i</sub> | 1.4 nM and 3100 nM for CB₁ and CB₂ receptors, respectively. |
Purity | ≥98% by HPLC |
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Référence | GTIN |
504191 | 0 |
Documentation
CB1 agonist ACEA - CAS 220556-69-4 - Calbiochem FDS
Titre |
---|
Références bibliographiques
Aperçu de la référence bibliographique |
---|
Di Marzo, V., et al. 1998. Trends Neurosci. 21, 521. Mechoulam, R., et al. 1994. Biochem. Pharmacol. 48, 1537. Pertwee, R.G. 1997. Pharmacol. Ther. 74, 129. Fernandez-Ruiz, J., et al. 2000. Trends Neurosci. 23, 14. Song, Z.H., et al. 2000. J. Pharmacol. Exp. Ther. 294, 204. Matsuda, L.A., et al. 1990. Nature 346, 561. Munro, S. et al. 1993. Nature 365, 61. Hillard, C.J., et al. 1999. J. Pharmacol. Exp. Ther. 289, 1427. |